Talphera TLPH
NASDAQ TLPH
$1.24 +0.01 (+1.23%)
As of: Sep 10, 2026 · 1:39 PM EDT

Talphera (TLPH) Profit After Tax (2010 - 2026)

Talphera (TLPH) posted Profit After Tax of -$4.3 million for Q2 2026, down 68.7% on a QoQ basis from -$2.6 million in Q1 2026, and down 23.59% year-over-year from -$5.6 million in Q2 2025.

Analysis

Talphera (TLPH) Profit After Tax (2010 - 2026) Analysis & Trends

Talphera has reported Profit After Tax for 17 years, with the latest figure at -$4.3 million in Q2 2026.

  • On a quarterly basis, Profit After Tax fell 23.59% year-over-year to -$4.3 million in Q2 2026; TTM through Jun 2026 was -$15.1 million, a 33.36% decrease from a year earlier, with the FY2025 full-year figure at -$14.4 million, down 10.45% from the prior year.
  • Profit After Tax was -$4.3 million for Q2 2026 at Talphera, down from -$2.6 million in the prior quarter.
  • The five-year high for Profit After Tax was $70.7 million in Q2 2022, with the low at -$8.7 million in Q1 2022.
  • Average Profit After Tax over 5 years is -$184277.8, with a median of -$3.9 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Profit After Tax jumped 817.32% in 2022, then slumped 136.46% in 2024.
  • Over 5 years, Profit After Tax stood at -$5.9 million in 2022, then advanced by 23.9% to -$4.5 million in 2023, then jumped by 58.6% to -$1.9 million in 2024, then plunged by 101.71% to -$3.8 million in 2025, then fell by 14.32% to -$4.3 million in 2026.
  • The last three Profit After Tax figures came in at -$4.3 million (Q2 2026), -$2.6 million (Q1 2026), and -$3.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 180.02 Bn 176.84 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 131.54 Bn 123.69 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 81.96 Bn 73.96 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 60.23 Bn 55.04 Bn 1.37 Bn 472.00 Mn
6 Moderna 53.85 Bn 48.72 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 33.13 Bn 29.82 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.88 Bn 30.59 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 29.23 Bn 29.23 Bn 1.16 Mn -290.61 Mn
10 Talphera 93.28 Mn 93.28 Mn - -4.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.31 Mn
Mar 31, 2026 -2.56 Mn
Dec 31, 2025 -3.77 Mn
Sep 30, 2025 -4.44 Mn
Jun 30, 2025 -3.49 Mn
Mar 31, 2025 -2.59 Mn
Dec 31, 2024 -1.87 Mn
Sep 30, 2024 -3.35 Mn
Jun 30, 2024 -3.83 Mn
Mar 31, 2024 -3.95 Mn
Dec 31, 2023 -4.52 Mn
Sep 30, 2023 -1.42 Mn
Jun 30, 2023 -4.37 Mn
Mar 31, 2023 -8.15 Mn
Dec 31, 2022 -5.94 Mn
Sep 30, 2022 -6.75 Mn
Jun 30, 2022 70.66 Mn
Mar 31, 2022 -8.67 Mn
Dec 31, 2021 -7.92 Mn
Sep 30, 2021 -8.38 Mn